Owner Elan Pharmaceuticals, Inc.

Inventors McConlogue, Lisa; Wang, Shuwen; Tung, Jay; Tatsuno, Gwen; Sinha, Sukanto; Power, Michael; John, Varghese; Frigon, Normand; Doane, Minh Tam; Basi, Guriqbal; Anderson, John P

Agent FB Rice

Pub. Number AU-A-2004203403

Parent 40009

Filing date 26 July 2004

Wipo publication date 19 August 2004

C07K 014/47 Peptides having more than 20 amino acids

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A61K 038/08 Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

A01K 067/027 Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C12N 001/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 005/16 Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells

C12N 015/57 Mutation or genetic engineering - acting on peptide bonds (3.4)

C07K 016/40 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C07K 007/06 Peptides having 5 to 20 amino acids in a fully defined sequence

C12N 009/64 Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin